Research study Program year 2022 Source: CMS Open Payments

Nn9924-4338

Research payments

$15,538

46 payments

Through program year 2022, $15,538 in research payments was reported against Nn9924-4338, across 46 payments, paid by Novo Nordisk AS.

Paid by: Novo Nordisk AS
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$225	1
2021	Research	$4,863	24
2020	Research	$8,825	20
2019	Research	$1,625	1

Breakdown

Who paid Research payments · program years 2019–2022

Novo Nordisk AS $15,538 46 payments

Who received the money Research payments · program years 2019–2022

Michael Morse Hematology & Oncology · Durham, NC $2,300 8 payments
Mark Schroeder Medical Oncology · Saint Louis, MO $2,138 6 payments
Bernard Chaitman Cardiovascular Disease · St Louis, MO $1,625 1 payment
Jamie Dwyer Nephrology · Nashville, TN $1,050 4 payments
Eliahu Feen Neurocritical Care · Marietta, GA $900 4 payments
Benglow Consulting Organisation paid for research $875 1 payment
Kevin Martin Nephrology · St Louis, MO $850 4 payments
David Bushinsky Nephrology · Rochester, NY $775 3 payments
Richard Bach Interventional Cardiology · Saint Louis, MO $750 3 payments
Gustavo Rodriguez Neurological Surgery · El Paso, TX $525 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.